While the potential role of tumor Foxp3 as prognostic biomarker of overall survival has been previously investigated, only two studies addressed this issue and draw accordant conclusion that high Foxp3 expression was associated with poor overall survival in patients with TSCC and OHSCC respectively [9, 10]. This evidence concerns the gene FOXP3 and neoplasm.